arXiv:2606.14031v1 Announce Type: new Abstract: Identifying conditions that a certain drug takes therapeutic effect on a target disease is crucial for clinical decision-making support. However, most existing biomedical information extraction methods have focused on identifying only relations between drugs and diseases, while largely overlooking the context-specific conditions where such relations can apply. To address this problem, we introduce the task of applicability condition extraction for therapeutic drug--disease relations from biomedical research literature. We create the first dataset
The increasing sophistication of AI in text analysis and the growing demand for personalized medicine are converging to make previously intractable information extraction tasks feasible and valuable.
This development can significantly enhance the precision of therapeutic interventions, reduce adverse drug reactions, and accelerate drug discovery by providing contextually rich insights from biomedical literature.
The ability to automatically extract applicability conditions for drug-disease relations moves beyond simple drug-disease association, enabling more nuanced and safer clinical decision support and opening new avenues for pharmaceutical research.
- · Pharmaceutical companies
- · Clinical researchers
- · AI/ML developers in healthcare
- · Patients
- · Traditional manual literature review processes
- · Trial-and-error drug prescription models
Improved patient outcomes due to more precise drug prescriptions and reduced side effects.
Faster and more efficient drug discovery and repurposing, leading to new treatments for complex diseases.
The development of truly personalized medicine, where drug regimens are tailored not just to genetics, but to dynamic applicability conditions for each patient.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.AI